NewAmsterdam Pha (NAMSW) Stock Price, News & Analysis
Company Description
NewAmsterdam Pha (NASDAQ: NAMSW) is classified in the Pharmaceutical Preparations sector.
NAMSW has gained 22.7% over the past year. Shares last traded at $16.51.
For FY2025, NewAmsterdam Pha reported revenue of $22.5M with net income of -$203.0M and diluted earnings per share of -$1.72. The company operates at a net profit margin of -902.1%.
This page collects what Stock Titan holds for NAMSW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
NewAmsterdam Pha (NAMSW) stock last closed at $16.51. Over the past 12 months, the stock has gained 22.7%.
NAMSW Rankings
Latest News
NewAmsterdam Pha has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, earnings. View all NAMSW news →
SEC Filings
NewAmsterdam Pha has filed 5 recent SEC filings, including 1 Form 3, 1 Form 4, 1 Form 144, 1 Form 144/A. The most recent filing was submitted on August 25, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NAMSW SEC filings →
Financial Highlights
NewAmsterdam Pha generated $22.5M in revenue in FY2025, operating income reached -$225.7M (-1002.9% operating margin), and net income was -$203.0M, reflecting a -902.1% net profit margin. Diluted earnings per share stood at -$1.72. The company generated -$147.8M in operating cash flow. With a current ratio of 7.88, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in NewAmsterdam Pha (NAMSW) currently stands at 43 shares, up 2.4% from the previous reporting period. Since September 2025, short interest has decreased by 97.9%.
Days to Cover History
Days to cover for NewAmsterdam Pha (NAMSW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 8.0 days.
NAMSW Company Profile & Sector Positioning
NewAmsterdam Pha (NAMSW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.
Investors comparing NAMSW often look at related companies in the same sector, including Dermata Therapeutics Inc (DRMAW), Pasithea Therapeutics Corp (KTTAW), Aspire Biopharma Holdings Inc (ASBPW), Cingulate (CINGW), and Estrella Immunopharma (ESLAW). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NAMSW's relative position within its industry.